DEA Planning to Cut Production of Opioid Medication

Share this content:
DEA Planning to Cut Production of Opioid Medication
DEA Planning to Cut Production of Opioid Medication

THURSDAY, Oct. 6, 2016 (HealthDay News) -- The U.S. Drug Enforcement Administration (DEA) says it has mandated significant cuts in the production of Schedule II opiate and opioid medication.

The opioids in question include drugs such as oxycodone, hydrocodone, hydromorphone, fentanyl, and morphine. The amount of these drugs allowed to be manufactured in the United States will be reduced by 25 percent or more in 2017, the DEA said. Production of certain opioid medications, such as hydrocodone, will be reduced by 34 percent, the agency said in a news release.

The DEA said it made the changes because legal prescriptions for these opioid medications have decreased, while illegal use of the drugs is on the rise.

The 2015 National Survey on Drug Use and Health found that 6.5 million Americans older than 12 had illegally used prescription medications in the previous month. That rate was second only to marijuana, and greater than past-month use of cocaine, heroin, and hallucinogens combined, according to the DEA.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

ASA: Male Stroke Patients Twice As Likely to Get Timely tPA

ASA: Male Stroke Patients Twice As Likely to ...

Researchers not sure why the disparity exists

CDC: Fatal Drug Overdoses More Than Doubled Since 1999

CDC: Fatal Drug Overdoses More Than Doubled Since ...

Whites, middle-aged adults hardest hit, researchers find

Rates of Resistant Infections Up in U.S. Children

Rates of Resistant Infections Up in U.S. Children

Research highlights increasing community vulnerability

is free, fast, and customized just for you!

Already a member?

Sign In Now »